OpenVSafe by OpenVAERS
Search V-safe

P9Z-14050-74506

2 vaccinations 2 coded responses 15 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
05-11
ZIP prefix
894 / NV
Registered
2021-11-19
Relationship
Child or adolescent in my care
Guardian
YH3-30927-06774
Race
White
Ethnicity
N/A

Timeline

  1. 2021-11-12
    Dose 1 — Pfizer-BioNTech
  2. 2021-11-19
    Registered in v-safe
  3. 2021-11-19
    Health check-in — day 7, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  4. 2021-11-26
    Health check-in — day 14, dose 1, dependent
    Feeling: Good
    Adult check-in
  5. 2021-12-03
    Dose 2 — Pfizer-BioNTech
  6. 2021-12-03
    Health check-in — day 0, dose 2, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-12-04
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  8. 2021-12-05
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  9. 2021-12-07
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  10. 2021-12-08
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  11. 2021-12-10
    Health check-in — day 7, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  12. 2021-12-17
    Health check-in — day 14, dose 2, dependent
    Feeling: Good
    Adult check-in
  13. 2021-12-24
    Health check-in — day 21, dose 2, dependent
    Feeling: Good
    Adult check-in
  14. 2022-01-02
    Health check-in — day 28, dose 2, dependent
    Feeling: Good
    Adult check-in
  15. 2022-01-09
    Health check-in — day 35, dose 2, dependent
    Feeling: Good
    Adult check-in
  16. 2022-01-14
    Survey response — day 42, dose 2, dependent
    MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend school
    Free text: Cold symptoms
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-03-04
  18. 2022-06-03
    Survey response — 6 months, dose 2, dependent
    MedDRA: Nasopharyngitis, Oropharyngeal pain, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school
    Free text: Cold type symptoms with sore throat. Negative for COVID
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-11-12Pfizer-BioNTech No
22021-12-03Pfizer-BioNTech No

Free text

Release 10 — day 42, dose 2, dependent

2022-01-14

Symptoms: Cold symptoms

Release 11 — 6 months, dose 2, dependent

2022-06-03

Symptoms: Cold type symptoms with sore throat. Negative for COVID

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNasopharyngitis · · ✓
SDOropharyngeal pain · · ✓
SDSARS-CoV-2 test negative · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…